Ep 76: KEYNOTE 054 7-year follow-up

from Melanoma Matters · host Melanoma Matters Pod

SummaryIn this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054There's a bit too much talk about weightlifting though...

Episode metadata supplied by the publisher feed · Published Dec 28, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep 76: KEYNOTE 054 7-year follow-up

0:00 28:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Melanoma Matters?

This episode is 28 minutes long.

When was this Melanoma Matters episode published?

This episode was published on December 28, 2025.

Can I download this Melanoma Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!